YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

US to invest $1.2B to secure potential COVID-19 vaccine

Posted online

The U.S. government agreed to pay $1.2 billion to AstraZeneca PLC to secure its supply of a potential COVID-19 vaccine.

The deal calls for the government to fund a 30,000-person vaccine trial starting this summer. The investment also would support the ramp-up of manufacturing capacity to make at least 300 million doses.

The vaccine was developed by the University of Oxford’s Jenner Institute.

Read more from MarketWatch.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Annual downtown holiday events combine for Nov. 21 celebration

Organizers hope to bolster client traffic to center city businesses.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences